Pharmacopeia
KETAMINE
Core pharmacology
- Legacy Cicm Level
Level 1
- Introduction
Phencyclidine (remember the street drug name PCP) derivative that
produces dissociative anesthesia- Indications Uses
Induction of anaesthesia
- Procedural sedation
- Analgesia
- ?Role in management of depression. - Recreational- Presentation
10, 50 or 100mg/ml
- Mechanism of action
NMDA receptor antagonism
- Inhibits excitatory signaling within CNS
- Also inhibits noradrenaline reuptake in sympathetic nerve terminals- Physiological effects
CNS: Causes dissociative anaesthesia
- Hallucinations
- Emergence deliriumCVS: Indirect sympathomimetic
chronotropy, inotrophy and Hypertension
Direct cardiodepressant
if depletion of NA hypotension
Resp - Bronchodilation- Adverse Effects Toxicity
Increased salivation - Upper airway reflexes intact laryngospasm - Hypotension if given in shock states - Emergence delirium
- Absorption
A: 20% oral bioavailability
- Protein binding
25%
- Volume of distribution
3l/kg
- Metabolism
Hepatic metabolism with active
norketamine metabolite- Excretion
Renal elimination
- Half-life
T1/2a 15 mins, T1/2b
2~3 hours, CSHT 40mins at 5 hours- Route And Dose
- 1mg/kg induction dose
- 10~20mg analgesia
Additional pharmacology
- Class Group
Non-Opiate Analgesic
Neurology & Sedation · Neurology & Sedation
- Class Group
Sedative / Hypnotic